Skip to main content

Point72 Asset Management, L.P.

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1603466 STAMFORD, CT

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$61,559,150
+$4,174,740 QoQ
Shares Held
2,433,168
-5.6% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#12
of 352 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Derivatives in ACAD

reported options exposure · as of Jun 30, 2026
CallValue
$359,260
CallShares
14,200
PutValue
$359,260
PutShares
14,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ACAD ranks #8 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ACAD
Acadia Pharmaceuticals Inc
This page
2,433,168 $61,559,150

All Filings in ACAD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,260 14,200
2026-06-30 $359,260 14,200
2026-06-30 $61,559,150 2,433,168
2026-03-31 $304,962 13,700
2026-03-31 $304,962 13,700
2026-03-31 $57,384,410 2,577,916
2025-12-31 $90,207,976 3,377,311
2025-09-30 $31,718,858 1,486,357
2025-06-30 $68,431,062 3,172,511
2025-03-31 $77,200,223 4,647,816
2024-12-31 $40,935,455 2,230,815
2024-06-30 $60,289,775 3,710,140
2024-06-30 $1,657,500 102,000
2024-03-31 $1,664,100 90,000
2024-03-31 $14,361,183 776,700
2023-12-31 $12,299,413 392,827
2023-09-30 $1,055,400 50,643
2023-06-30 $21,361,627 891,926
2023-03-31 $12,411,902 659,506
2022-12-31 $17,765,128 1,115,900
2021-03-31 $5,131,620 198,900
2020-12-31 $8,933,166 167,100
2020-09-30 $23,850,543 578,195
2020-06-30 $9,621,779 198,510